Amgen (NASDAQ:AMGN), a United States-based biopharmaceutical company, announced on Friday that it has increased its dividend for the first quarter of 2022.

The company has declared a dividend of USD1.94 per share for the first quarter of 2022, up 10% compared to the year-ago period.

The dividend will be paid to shareholders of record at 15 February 2022 on 8 March 2022.

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index.